Jakub Neradil

1.5k total citations
43 papers, 1.1k citations indexed

About

Jakub Neradil is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jakub Neradil has authored 43 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 14 papers in Oncology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jakub Neradil's work include Cancer Cells and Metastasis (8 papers), Sarcoma Diagnosis and Treatment (8 papers) and Microtubule and mitosis dynamics (6 papers). Jakub Neradil is often cited by papers focused on Cancer Cells and Metastasis (8 papers), Sarcoma Diagnosis and Treatment (8 papers) and Microtubule and mitosis dynamics (6 papers). Jakub Neradil collaborates with scholars based in Czechia, Australia and United States. Jakub Neradil's co-authors include Renata Veselská, Aleš Hampl, Jaroslav Štěrba, Lívia Eiselleová, Petr Dvořák, J. Škoda, Karel Zitterbart, Tomáš Loja, Iva Slaninová and Gabriela Mladonická Pavlasová and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Jakub Neradil

40 papers receiving 1.1k citations

Peers

Jakub Neradil
Renata Veselská Czechia
Sylvia Kaden Germany
María Sol Brassesco Brazil
Natasha M. Savage United States
Brittney‐Shea Herbert United States
Byung‐Gyu Kim United States
Direna Alonso‐Curbelo United States
Eva M. Garrido‐Martín Spain
Laura Alaniz Argentina
Renata Veselská Czechia
Jakub Neradil
Citations per year, relative to Jakub Neradil Jakub Neradil (= 1×) peers Renata Veselská

Countries citing papers authored by Jakub Neradil

Since Specialization
Citations

This map shows the geographic impact of Jakub Neradil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jakub Neradil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jakub Neradil more than expected).

Fields of papers citing papers by Jakub Neradil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jakub Neradil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jakub Neradil. The network helps show where Jakub Neradil may publish in the future.

Co-authorship network of co-authors of Jakub Neradil

This figure shows the co-authorship network connecting the top 25 collaborators of Jakub Neradil. A scholar is included among the top collaborators of Jakub Neradil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jakub Neradil. Jakub Neradil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zambo, Iva Staniczková, et al.. (2025). Biomarkers and therapeutic targets in giant cell tumor of bone: A comprehensive review. Bone. 199. 117566–117566.
2.
Apostolopoulos, Vasileios, et al.. (2024). Micro-CT, Mechanical, and Histological Examination of the Effect of Local Adjuvants on Porcine Cortical Bone Following Intralesional Curettage of Bone Tumors. Annals of Surgical Oncology. 31(9). 6282–6290. 1 indexed citations
3.
Apostolopoulos, Vasileios, et al.. (2024). ASO Author Reflections: The Effect of Local Adjuvants on Cortical Bone Following Intralesional Curettage of Bone Tumors. Annals of Surgical Oncology. 31(9). 6333–6334.
4.
Leck, Lionel, et al.. (2023). Mitoribosomal synthetic lethality overcomes multidrug resistance in MYC-driven neuroblastoma. Cell Death and Disease. 14(11). 747–747. 5 indexed citations
5.
Chlapek, Petr, et al.. (2022). Thiosemicarbazones Can Act Synergistically with Anthracyclines to Downregulate CHEK1 Expression and Induce DNA Damage in Cell Lines Derived from Pediatric Solid Tumors. International Journal of Molecular Sciences. 23(15). 8549–8549. 3 indexed citations
6.
7.
Škoda, J., Jakub Neradil, Petr Chlapek, et al.. (2020). Novel Thiosemicarbazones Sensitize Pediatric Solid Tumor Cell-Types to Conventional Chemotherapeutics through Multiple Molecular Mechanisms. Cancers. 12(12). 3781–3781. 8 indexed citations
8.
Neradil, Jakub, Michal Kýr, Leoš Křen, et al.. (2019). Phospho-Protein Arrays as Effective Tools for Screening Possible Targets for Kinase Inhibitors and Their Use in Precision Pediatric Oncology. Frontiers in Oncology. 9. 930–930. 9 indexed citations
9.
10.
Škoda, J., Tomáš Loja, Iva Staniczková Zambo, et al.. (2016). Cancer stem cell markers in pediatric sarcomas: Sox2 is associated with tumorigenicity in immunodeficient mice. Tumor Biology. 37(7). 9535–9548. 29 indexed citations
11.
Škoda, J., Markéta Hermanová, Tomáš Loja, et al.. (2016). Co-Expression of Cancer Stem Cell Markers Corresponds to a Pro-Tumorigenic Expression Profile in Pancreatic Adenocarcinoma. PLoS ONE. 11(7). e0159255–e0159255. 36 indexed citations
12.
Neradil, Jakub, et al.. (2016). Non-DHFR-mediated effects of methotrexate in osteosarcoma cell lines: epigenetic alterations and enhanced cell differentiation. Cancer Cell International. 16(1). 14–14. 18 indexed citations
13.
Neradil, Jakub, et al.. (2016). Much more than you expected: The non-DHFR-mediated effects of methotrexate. Biochimica et Biophysica Acta (BBA) - General Subjects. 1861(3). 499–503. 40 indexed citations
14.
Neradil, Jakub, et al.. (2015). Overexpression of the ∆Np73 isoform is associated with centrosome amplification in brain tumor cell lines. Tumor Biology. 36(10). 7483–7491. 8 indexed citations
15.
Neradil, Jakub, J. Škoda, Josef Jaroš, et al.. (2015). Atypical nuclear localization of CD133 plasma membrane glycoprotein in rhabdomyosarcoma cell lines. International Journal of Molecular Medicine. 36(1). 65–72. 19 indexed citations
16.
Škoda, J., Jakub Neradil, Karel Zitterbart, Jaroslav Štěrba, & Renata Veselská. (2013). EGFR signaling in the HGG-02 glioblastoma cell line with an unusual loss of EGFR gene copy. Oncology Reports. 31(1). 480–487. 9 indexed citations
17.
Neradil, Jakub, Gabriela Mladonická Pavlasová, & Renata Veselská. (2012). New mechanisms for an old drug; DHFR- and non-DHFR-mediated effects of methotrexate in cancer cells.. PubMed. 25 Suppl 2. 2S87–92. 48 indexed citations
18.
Eiselleová, Lívia, et al.. (2008). Comparative study of mouse and human feeder cells for human embryonic stem cells. The International Journal of Developmental Biology. 52(4). 353–363. 115 indexed citations
19.
Veselská, Renata, et al.. (2006). Nestin expression in the cell lines derived from glioblastoma multiforme. BMC Cancer. 6(1). 32–32. 69 indexed citations
20.
Neradil, Jakub, Renata Veselská, & Jiřı́ Slanina. (2003). UVC-Protective Effect of Caffeic Acid on Normal and Transformed Human Skin Cells in Vitro. Folia Biologica. 49(5). 197–202. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Renata Veselská Breakdown of academic impact, for papers by Sylvia Kaden Breakdown of academic impact, for papers by María Sol Brassesco Breakdown of academic impact, for papers by Natasha M. Savage Breakdown of academic impact, for papers by Brittney‐Shea Herbert Breakdown of academic impact, for papers by Byung‐Gyu Kim Breakdown of academic impact, for papers by Direna Alonso‐Curbelo Breakdown of academic impact, for papers by Eva M. Garrido‐Martín Breakdown of academic impact, for papers by Laura Alaniz
Rankless by CCL
2026